telehealth access

The science is clear: abortion by medication is safe and effective

By Kelly Cleland
on August 21, 2021

The pandemic has shown us that it’s time to change the way we get health care and that essential health care, including abortion, has always been out of reach for far too many. As we look ahead to the future of care, the science is clear: medication abortion care is safe and effective, and it’s past time to remove the restrictions on it. Now, actions from the FDA and new research show us that removing the restrictions on medication abortion care has the potential to expand access for many people who need care. The July 2021 special issue of the journal Contraception focuses on the restrictions on medication abortion, mifepristone, including its impacts on safety and efficacy, access to abortion, and burdens on patients and providers.

Continued: https://www.scientificamerican.com/article/the-fda-should-remove-its-restrictions-on-the-abortion-pill-mifepristone/

Ensuring Access to Abortion at the State Level: Selected Examples and Lessons

Elizabeth Nash,Guttmacher Institute
Megan K. Donovan,Guttmacher Institute
First published online: January 9, 2019

The October 2018 appointment of Justice Brett Kavanaugh to the U.S. Supreme Court has called into question the future of Roe v. Wade and abortion access in the United States. Just one month after Justice Kavanaugh took his seat on the bench, voters in Alabama and West Virginia approved state constitutional amendments intended to allow for additional abortion restrictions or even pave the way for outright bans on abortion in the event Roe is undermined or overturned.1

Although the changing composition of the Supreme Court has heightened the risks, efforts to restrict abortion are not new. Policymakers hostile to abortion have been working to undermine abortion care since Roe was decided. As a result, access to abortion already looks very different from state to state, and a person’s access to timely, affordable abortion care can be profoundly impacted by her race, socioeconomic status and available resources.

Continued: https://www.guttmacher.org/gpr/2019/01/ensuring-access-abortion-state-level-selected-examples-and-lessons

The FDA Should Remove Its Restrictions on the ‘Abortion Pill’ Mifepristone

USA – Ensuring Access to Abortion at the State Level: Selected Examples and Lessons